Raquel R. D.
- Country
- Spain
- Department
- Servicio de Dermatologia
Research Overview
- OptIMMize-2: A Phase 3 Multicenter, Single-arm, Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of Risankizumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Completed Participation in Study M19-977 (OptIMMize-1).
- INCB 18424-320: A phase 3, double-blind, randomised, vehicle-controlled, efficacy and safety study of ruxolitinib cream in participants with Prurigo Nodularis. Topical ruxolitinib evaluation in Prurigo Nodularis (TRuE-PN2)
- Efficacy and Safety Evaluation of SAR441566 in Adults with Moderate to Severe Plaque Psoriasis: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 41 of 140 partner sites.
Specializations
Dermatologic Inflammatory Disease
The investigator is involved in clinical research on chronic inflammatory skin disorders, with attention to atopic dermatitis, psoriasis, hidradenitis suppurativa, alopecia areata, bullous pemphigoid, and prurigo nodularis.
- Atopic dermatitis and eczema
- Plaque psoriasis and psoriatic arthritis
- Hidradenitis suppurativa
- Alopecia areata
- Bullous pemphigoid
Research activity in this area also includes immune-mediated skin disease and symptom control in cutaneous inflammation.
Oncodermatology and Skin Cancer
The clinical portfolio includes trials in melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, Merkel cell carcinoma, and other skin cancers, with interest in advanced and metastatic disease settings.
- Melanoma
- Cutaneous squamous cell carcinoma
- Basal cell carcinoma
- Merkel cell carcinoma
- Cutaneous T-cell lymphoma
There is also involvement in studies addressing skin-directed therapy for malignancies arising in the dermatologic setting.
Autoimmune and Connective Tissue Disorders
Clinical research extends to systemic immune disorders with cutaneous involvement, including systemic lupus erythematosus, cutaneous lupus erythematosus, psoriatic arthritis, dermatomyositis, and systemic sclerosis.
- Systemic lupus erythematosus
- Cutaneous lupus erythematosus
- Dermatomyositis
- Systemic sclerosis
- Psoriatic arthritis
The investigator’s work in this domain reflects a focus on autoimmune skin manifestations and related multisystem inflammatory disease.
Urologic and Genitourinary Oncology
The investigator is also active in trials involving urothelial carcinoma, bladder cancer, renal cell carcinoma, and prostate cancer, including advanced and recurrent disease contexts.
- Urothelial carcinoma
- Bladder cancer
- Renal cell carcinoma
- Prostate cancer
- Metastatic genitourinary malignancies
These activities place emphasis on genitourinary cancer therapy and treatment options for difficult-to-manage solid tumors.
Breast and Gynecologic Oncology
Research involvement includes breast cancer, endometrial cancer, ovarian cancer, cervical cancer, and triple-negative breast cancer, with attention to both localized and advanced disease.
- Breast cancer
- Triple-negative breast cancer
- Endometrial cancer
- Ovarian cancer
- Cervical cancer
The investigator contributes to studies centered on hormone receptor-positive breast cancer and broader gynecologic oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.